Breaking News Instant updates and real-time market news.

AERI

Aerie Pharmaceuticals

$53.40

-5.2 (-8.87%)

16:03
09/20/17
09/20
16:03
09/20/17
16:03

Aerie announces FDA Advisory Committee meeting for Rhopressa 0.02%

Aerie Pharmaceuticals announced that a meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee of the FDA has been scheduled for October 13 to review the company's New Drug Application, or NDA, for Rhopressa 0.02% for the treatment of patients with open-angle glaucoma or ocular hypertension. Aerie submitted the NDA for Rhopressa to the FDA in February, following which the FDA set a PDUFA goal date of February 28, 2018 for the completion of its review of the Rhopressa NDA.

  • 25

    Sep

  • 28

    Feb

AERI Aerie Pharmaceuticals
$53.40

-5.2 (-8.87%)

09/07/17
MZHO
09/07/17
INITIATION
Target $70
MZHO
Buy
Aerie Pharmaceuticals initiated with a Buy on glaucoma opportunity at Mizuho
As previously reported, Mizuho initiated Aeri Pharmaceuticals with a Buy and a $70 price target. Analyst Difei.Yang said Aeri is well positioned for FDA approvals of its two glaucoma drugs, Rhopressa and Roclatan in 2018-2019. If both are approved, he said the drugs would bring options for treating glaucoma with the first new mechanism of actions in nearly 20 years and sees potential for a buyout ahead of the FDA approvals in 2018
09/06/17
MZHO
09/06/17
INITIATION
Target $70
MZHO
Buy
Aerie Pharmaceuticals initiated with a Buy at Mizuho
Mizuho initiated Aerie Pharmaceuticals with a Buy and a $70 price target.
08/17/17
ADAM
08/17/17
NO CHANGE
Target $65
ADAM
Buy
Aerie Pharmaceuticals manufacturing clearance removes overhang, says Canaccord
Canaccord analyst Dewey Steadman said the clearance of Aeri Pharmaceuticals' manufacturing clearance removes an overhang over the shares. He thinks the path is now cleared toward Rhopressa's February PDUFA and thinks now is one of the few opportunities ahead to invest in the shares ahead of the company's first potential approval. Steadman reiterated his Buy rating and $65 price target on Aeri Pharmaceuticals shares.
07/03/17
ADAM
07/03/17
NO CHANGE
Target $65
ADAM
Buy
Aerie price target raised to $65 from $60 at Canaccord
Canaccord analyst Dewey Steadman said he remains confident in Aerie Pharmaceuticals' ability to launch Rhopressa as early at the first half of next year, noting that the company is preparing for an FDA advisory committee meeting that could happen before Thanksgiving. Steadman, who sees Rhopressa as a $500M product at its peak, also said he's confident in a potential Roclatan approval in 2019, stating that could be a $1B product. The analyst keeps a Buy rating on Aerie shares and raised his price target on the stock to $65 from $60.

TODAY'S FREE FLY STORIES

XENE

Xenon Pharmaceuticals

$3.60

-0.025 (-0.69%)

08:37
02/20/18
02/20
08:37
02/20/18
08:37
Hot Stocks
Xenon Pharmaceuticals initiates Phase 1 clinical trial of XEN901 »

Xenon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XENE

Xenon Pharmaceuticals

$3.60

-0.025 (-0.69%)

08:37
02/20/18
02/20
08:37
02/20/18
08:37
Hot Stocks
Xenon Pharmaceuticals »

Xenon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHMG

Chemung Financial

$43.90

0.09 (0.21%)

08:37
02/20/18
02/20
08:37
02/20/18
08:37
Upgrade
Chemung Financial rating change  »

Chemung upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$104.78

1.55 (1.50%)

08:36
02/20/18
02/20
08:36
02/20/18
08:36
Hot Stocks
Walmart sees ecommerce losses 'about the same' in FY19 vs. FY18 »

Walmart CFO Brett Biggs,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Feb

  • 07

    Mar

HII

Huntington Ingalls

$265.70

10.31 (4.04%)

08:36
02/20/18
02/20
08:36
02/20/18
08:36
Recommendations
Huntington Ingalls analyst commentary  »

Huntington Ingalls price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ECL

Ecolab

$131.49

-0.28 (-0.21%)

08:35
02/20/18
02/20
08:35
02/20/18
08:35
Earnings
Ecolab sees FY18 adjusted EPS $5.25-$5.45, consensus $5.34 »

The 2018 outlook shown…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 30

    May

GPC

Genuine Parts

$99.83

-1.08 (-1.07%)

08:35
02/20/18
02/20
08:35
02/20/18
08:35
Hot Stocks
Genuine Parts reports Q4 sales for Automotive Group up 16.7% »

Fourth quarter sales for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

IMAX

Imax

$22.60

-0.3 (-1.31%)

08:34
02/20/18
02/20
08:34
02/20/18
08:34
Hot Stocks
Imax announces record $35M global debut of Marvel Studios' Black Panther »

IMAX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 05

    Mar

EXPD

Expeditors

$64.12

-0.07 (-0.11%)

08:33
02/20/18
02/20
08:33
02/20/18
08:33
Earnings
Expeditors reports Q4 EPS 92c, consensus 63c »

Reports Q4 revenue $1.9B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADI

Analog Devices

$86.09

0.69 (0.81%)

08:33
02/20/18
02/20
08:33
02/20/18
08:33
Upgrade
Analog Devices rating change  »

Analog Devices upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

GPC

Genuine Parts

$99.83

-1.08 (-1.07%)

08:32
02/20/18
02/20
08:32
02/20/18
08:32
Earnings
Genuine Parts sees FY18 EPS $5.60-$5.75, consensus $5.93 »

The company is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

ECL

Ecolab

$131.49

-0.28 (-0.21%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Earnings
Ecolab reports Q4 adjusted EPS $1.39, consensus $1.39 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 30

    May

SMP

Standard Motor

$48.20

0.3 (0.63%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Earnings
Standard Motor reports Q4 cont ops EPS 54c, consensus 38c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AAPL

Apple

$172.43

-0.56 (-0.32%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Technical Analysis
Technical Take: Apple slips in early trading »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

GPC

Genuine Parts

$99.83

-1.08 (-1.07%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Earnings
Genuine Parts reports Q4 adjusted EPS $1.19, consensus $1.05 »

Reports Q4 revenue $4.2B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

GPS

Gap

$33.27

-0.06 (-0.18%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Hot Stocks
Gap announces departure of Gap brand President and CEO Jeff Kirwan »

Gap Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 18

    Mar

ANY

Sphere 3D

$2.33

0.0999 (4.48%)

, FALC

FalconStor

$0.19

0.003 (1.65%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Options
Two option delistings on February 20th »

Option delistings…

ANY

Sphere 3D

$2.33

0.0999 (4.48%)

FALC

FalconStor

$0.19

0.003 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RUSHA

Rush Enterprises

$42.77

-0.325 (-0.75%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Recommendations
Rush Enterprises analyst commentary  »

Rush Enterprises price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:29
02/20/18
02/20
08:29
02/20/18
08:29
General news
Stocks point to lower start to week as Walmart weighs on Dow »

Stock futures are…

GOOD

Gladstone

$17.65

0.24 (1.38%)

08:28
02/20/18
02/20
08:28
02/20/18
08:28
Hot Stocks
Gladstone announces sale of Arlington, TX $5.6M »

Gladstone announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAN

Aaron's

$43.40

-0.39 (-0.89%)

, LOW

Lowe's

$96.31

-0.2 (-0.21%)

08:28
02/20/18
02/20
08:28
02/20/18
08:28
Recommendations
Aaron's, Lowe's analyst commentary  »

Aaron's Progressive…

AAN

Aaron's

$43.40

-0.39 (-0.89%)

LOW

Lowe's

$96.31

-0.2 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 07

    Mar

LVMUY

LVMH

$61.94

0.68 (1.11%)

08:27
02/20/18
02/20
08:27
02/20/18
08:27
Hot Stocks
LVMH names Serge Brunschwig as Chairman and CEO of Fendi »

The LVMH Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$77.27

2.66 (3.57%)

08:26
02/20/18
02/20
08:26
02/20/18
08:26
Earnings
Wabtec reports Q4 adj. EPS 90c, consensus 92c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Mar

ATNX

Athenex

$16.66

-0.11 (-0.66%)

08:25
02/20/18
02/20
08:25
02/20/18
08:25
Hot Stocks
Athenex announces Phase II clinical study results for KX2-391 ointment »

Athenex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

08:25
02/20/18
02/20
08:25
02/20/18
08:25
General news
Fedspeak is backloaded during the week: »

Fedspeak is backloaded…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.